Literature DB >> 22407993

Clostridium difficile infection: the scope of the problem.

Erik Dubberke1.   

Abstract

Clostridium difficile infection (CDI) is increasingly common, and it is associated with significant morbidity, mortality, and cost burden for patients and the healthcare system. The severity and rates of recurrent CDI and associated mortality are also increasing. This article is an overview of the changes in CDI epidemiology that have occurred since the turn of the century and the current scope of the problem. The 3 articles that follow in this supplement address the diagnosis and treatment of initial and recurrent CDI, and current practice guidelines for the prevention and control of CDI in the hospital setting.
Copyright © 2012 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22407993     DOI: 10.1002/jhm.1916

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  27 in total

1.  SpoIIID-mediated regulation of σK function during Clostridium difficile sporulation.

Authors:  Keyan Pishdadian; Kelly A Fimlaid; Aimee Shen
Journal:  Mol Microbiol       Date:  2014-12-19       Impact factor: 3.501

Review 2.  Economics and financing of vaccines for diarrheal diseases.

Authors:  Sarah M Bartsch; Bruce Y Lee
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

Review 3.  Adult vaccination.

Authors:  Kena A Swanson; H Josef Schmitt; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  David G Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

Review 5.  Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.

Authors:  Robert A Britton; Vincent B Young
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

Review 6.  Treatment Strategies for Recurrent Clostridium difficile Infection.

Authors:  Christine Leong; Sheryl Zelenitsky
Journal:  Can J Hosp Pharm       Date:  2013-11

7.  Variation in germination of Clostridium difficile clinical isolates correlates to disease severity.

Authors:  Paul E Carlson; Alyssa M Kaiser; Sarah A McColm; Jessica M Bauer; Vincent B Young; David M Aronoff; Philip C Hanna
Journal:  Anaerobe       Date:  2015-02-11       Impact factor: 3.331

Review 8.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

Review 9.  Updates to Clostridium difficile Spore Germination.

Authors:  Travis J Kochan; Matthew H Foley; Michelle S Shoshiev; Madeline J Somers; Paul E Carlson; Philip C Hanna
Journal:  J Bacteriol       Date:  2018-07-25       Impact factor: 3.490

10.  The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.

Authors:  Paul E Carlson; Seth T Walk; Alexandra E T Bourgis; Melissa W Liu; Fatos Kopliku; Eugene Lo; Vincent B Young; David M Aronoff; Philip C Hanna
Journal:  Anaerobe       Date:  2013-04-20       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.